Found 513 results
Valisure is suing U.S. Pharmacopeia, alleging false claims about its drug testing methods and an attempt to undermine it...
Bristol Myers Squibb's approval of Zenbexus for multiple myeloma highlights its new drug class, while a lawsuit over del...
Bristol Myers Squibb receives FDA clearance for a novel myeloma treatment, while PBMs shift towards greater price transp...
Every new parent grapples with a mix of emotions and decisions, often feeling overwhelmed. A pediatrician shares valuabl...
The FTC is investigating Epic Systems for potential antitrust violations related to its market dominance and employment...
The FDA now requires manufacturers to disclose food additive details, enhancing oversight for substances previously lack...
The FDA has rejected ITM-11 due to manufacturing concerns, hindering its potential as a competitor to Novartis’ treatmen...
Abortion care is evolving, with patients increasingly turning to digital solutions for reliable information and medical...
Medicare's “Bridge” program aims to lower costs for GLP-1 medications, yet its complexity may hinder patient access to a...
Nurses are increasingly spotlighting the risks of clinical AI, advocating for a collaborative approach to its developmen...
MoonLake Immunotherapeutics faces scrutiny for vague disclosures on its autoimmune drug candidate, raising questions abo...
Skylark Bio has initiated a clinical trial aimed at treating hearing loss in children with GJB2 mutations, following adv...
FDA nixes a radiopharma drug by ITM Isotope Technologies, while Hims & Hers plans to enter the peptides market amidst ev...
Splitting the MMR vaccine could lead to missed doses and increased illness among children, echoing past lessons from vac...
The FDA has recently approved a new therapeutic drug and a vaccine, shaping the future direction of biotechnology and ad...
A recent study reveals tau protein’s unexpected influence on cellular function, suggesting novel strategies for Alzheime...
A recent Medicare policy change has postponed the price negotiations for a major AbbVie drug, potentially impacting taxp...
Replimune's advanced melanoma drug, RP1, receives FDA approval after a challenging path, bringing hope to patients with...
Felix Wong's biotech startup thrives in California's culture despite his Massachusetts roots and impressive academic ped...
As AI tools proliferate in healthcare, the erosion of physician autonomy raises questions about clinical judgment, respo...